Brugada Syndrome Panel
Use
This test is designed for individuals with relevant features who have a clinical or suspected diagnosis of Brugada syndrome. It also serves those who have a family member with Brugada syndrome but without previous genetic testing or individuals without access to specific variant information for a family member who has genetically-confirmed Brugada syndrome.
Special Instructions
This test offers STAT testing that delivers results within 7 to 16 days with an additional surcharge. It also supports exome-wide CNV analysis as an add-on when ordered with PGxome-based or custom panels, but not available for PG-Select panels, Sanger sequencing, and other test methods.
Limitations
Tests were developed following CLIA and CAP regulations, yet have not been cleared or approved by the US FDA. Test results should be interpreted in the context of clinical information provided as they are dependent on the quality of such information.
New York Approved
Methodology
NGS (WES)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided